Nurix Therapeutics, Inc.: shareholders and insiders

NRIXNASDAQHealthcare · Pharmaceutical Preparations

Price

$14.73

November 16, 2026Market cap $1.6B

What Ploutos Investor adds for Nurix Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from FY2019
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 33% since Oct 13, 2026, when the 10-Q these figures come from was filed ($22.13 then, $14.73 on Nov 16, 2026). The figures date from before that move.10-Q
  • Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.

Insiders and their shares

Purchases and sales by officers and directors from Nov 17, 2025 to Nov 4, 2026, from their own Form 4 filings.

21 Form 4s

Bought on the market

–

nobody

Sold on the market

$5.8M

4 people

From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan77%
  • The rest23%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 17, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $5.1M by 4 people

  • 2025: no buys, sold $709.2K by 1 person
  • 2026: no buys, sold $5.1M by 4 people
  • Nov 4, 2026Houte Hans vanChief Financial Officer
    Kind10b5-1
  • Nov 4, 2026Houte Hans vanChief Financial Officer
    Kind10b5-1
  • Nov 3, 2026Christine RingChief Legal Officer
    Kind10b5-1
  • Nov 2, 2026Christine RingChief Legal Officer
    Kind10b5-1
  • Nov 2, 2026Christine RingChief Legal Officer
    Kind10b5-1
  • Nov 2, 2026Christine RingChief Legal Officer
    Kind10b5-1
  • Nov 2, 2026Gwenn HansenChief Scientific Officer
    Kind10b5-1
  • Nov 2, 2026Gwenn HansenChief Scientific Officer
    Kind10b5-1
  • Oct 30, 2026Houte Hans vanChief Financial Officer
    Kind
  • Oct 30, 2026Houte Hans vanChief Financial Officer
    Kind
  • Oct 30, 2026Houte Hans vanChief Financial Officer
    Kind
  • Oct 30, 2026Houte Hans vanChief Financial Officer
    Kind
  • Oct 30, 2026Christine RingChief Legal Officer
    Kind
  • Oct 30, 2026Christine RingChief Legal Officer
    Kind
  • Oct 30, 2026Christine RingChief Legal Officer
    Kind
  • Oct 30, 2026Christine RingChief Legal Officer
    Kind
  • Oct 30, 2026Gwenn HansenChief Scientific Officer
    Kind10b5-1
  • Oct 30, 2026Gwenn HansenChief Scientific Officer
    Kind10b5-1
  • Oct 30, 2026Gwenn HansenChief Scientific Officer
    Kind10b5-1
  • Oct 30, 2026Gwenn HansenChief Scientific Officer
    Kind10b5-1
  • Oct 15, 2026Gwenn HansenChief Scientific Officer
    Kind10b5-1
  • Oct 15, 2026Gwenn HansenChief Scientific Officer
    Kind10b5-1
  • Oct 14, 2026Julia P GregoryDirector
    Kind
  • Oct 14, 2026Julia P GregoryDirector
    Kind
  • Oct 2, 2026Christine RingChief Legal Officer
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 2, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by NRIX's officers and directors from 2021 up to November 16, 2025, 5 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

9 Holders over 5%Nov 5, 2026 Latest filing
  • BlackRock, Inc.
    Share of class8.20%
  • Redmile Group, LLCwith 2 more persons
    Share of class8.10%
  • Vestal Point Capital, LPwith 1 more person
    Share of class7.80%
  • Deep Track Capital, LPwith 2 more persons
    Share of class7.45%
  • Baker Bros. Advisors LPwith 3 more persons
    Share of class7.20%
  • Rubric Capital Management LPwith 1 more person
    Share of class6.96%
  • Perceptive Advisors LLCwith 2 more persons
    Share of class5.30%
  • T. Rowe Price Associates, Inc.
    Share of class5.30%
  • Vanguard Capital Management
    Share of class5.03%
Fell to 5% or less (5)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • FMR4.20%Nov 5, 202613G/A
  • The Vanguard Group0.00%Mar 27, 202613G/A
  • Commodore Capital LP4.90%Nov 14, 202513G/A
  • Wellington Management Group LLP4.20%May 12, 202513G/A
  • ARK Investment Management LLC0.00%Jan 10, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Jun 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter+9.9%
  • Point72 (Cohen)
    In the quarter-84%
  • Millennium Mgmt (Englander)
    In the quarter-96%
  • D.E. Shaw
    In the quarter-46%
  • AQR Capital
    In the quarter×10.9

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 18.9% of its shares outstanding were held short, +16.7% since the report before.

Shares held short
20.61M
18.9%
Since the report before17.66M on Sep 30, 2026
+16.7%
9.2
2.24M
More days to cover thanof 4,578 US-listed companies with enough volume
88%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 7.13M
  • Nov 15, 2023: Shares held short 7.44M
  • Nov 30, 2023: Shares held short 8.33M
  • Dec 15, 2023: Shares held short 8.83M
  • Dec 29, 2023: Shares held short 6.59M
  • Jan 12, 2024: Shares held short 7.01M
  • Jan 31, 2024: Shares held short 7.29M
  • Feb 15, 2024: Shares held short 7.27M
  • Feb 29, 2024: Shares held short 6.85M
  • Mar 15, 2024: Shares held short 6.41M
  • Mar 28, 2024: Shares held short 6.97M
  • Apr 15, 2024: Shares held short 7.04M
  • Apr 30, 2024: Shares held short 6.90M
  • May 15, 2024: Shares held short 7.28M
  • May 31, 2024: Shares held short 7.39M
  • Jun 14, 2024: Shares held short 7.60M
  • Jun 28, 2024: Shares held short 8.07M
  • Jul 15, 2024: Shares held short 8.84M
  • Jul 31, 2024: Shares held short 9.32M
  • Aug 15, 2024: Shares held short 9.24M
  • Aug 30, 2024: Shares held short 9.26M
  • Sep 13, 2024: Shares held short 9.36M
  • Sep 30, 2024: Shares held short 9.08M
  • Oct 15, 2024: Shares held short 9.24M
  • Oct 31, 2024: Shares held short 9.46M
  • Nov 15, 2024: Shares held short 9.60M
  • Nov 29, 2024: Shares held short 9.35M
  • Dec 13, 2024: Shares held short 9.83M
  • Dec 31, 2024: Shares held short 10.79M
  • Jan 15, 2025: Shares held short 10.87M
  • Jan 31, 2025: Shares held short 10.95M
  • Feb 14, 2025: Shares held short 11.36M
  • Feb 28, 2025: Shares held short 11.60M
  • Mar 14, 2025: Shares held short 12.17M
  • Mar 31, 2025: Shares held short 12.16M
  • Apr 15, 2025: Shares held short 14.39M
  • Apr 30, 2025: Shares held short 13.69M
  • May 15, 2025: Shares held short 14.12M
  • May 30, 2025: Shares held short 14.09M
  • Jun 13, 2025: Shares held short 14.44M
  • Jun 30, 2025: Shares held short 14.07M
  • Jul 15, 2025: Shares held short 13.95M
  • Jul 31, 2025: Shares held short 13.03M
  • Aug 15, 2025: Shares held short 12.88M
  • Aug 29, 2025: Shares held short 12.81M
  • Sep 15, 2025: Shares held short 13.05M
  • Sep 30, 2025: Shares held short 13.04M
  • Oct 15, 2025: Shares held short 13.87M
  • Oct 31, 2025: Shares held short 13.12M
  • Nov 14, 2025: Shares held short 14.08M
  • Nov 28, 2025: Shares held short 14.49M
  • Dec 15, 2025: Shares held short 13.64M
  • Dec 31, 2025: Shares held short 14.64M
  • Jan 15, 2026: Shares held short 15.20M
  • Jan 30, 2026: Shares held short 14.96M
  • Feb 13, 2026: Shares held short 15.25M
  • Feb 27, 2026: Shares held short 15.97M
  • Mar 13, 2026: Shares held short 16.18M
  • Mar 31, 2026: Shares held short 18.13M
  • Apr 15, 2026: Shares held short 19.20M
  • Apr 30, 2026: Shares held short 19.20M
  • May 15, 2026: Shares held short 18.63M
  • May 29, 2026: Shares held short 19.32M
  • Jun 15, 2026: Shares held short 20.02M
  • Jun 30, 2026: Shares held short 17.80M
  • Jul 15, 2026: Shares held short 17.98M
  • Jul 31, 2026: Shares held short 18.35M
  • Aug 14, 2026: Shares held short 17.98M
  • Aug 31, 2026: Shares held short 17.95M
  • Sep 15, 2026: Shares held short 17.98M
  • Sep 30, 2026: Shares held short 17.66M
  • Oct 15, 2026: Shares held short 20.61M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading28.8% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 28.8% of the shares in the reported trades were short sales, against 46.2% in the 14 before.

Last 14 sessionsOct 28, 2026 – Nov 16, 2026
28.8%
The 14 beforeOct 8, 2026 – Oct 27, 2026
46.2%
Change
-17.4 pts
Short sales a dayon average, of 1.46M shares
420.0K
More than atof 3,668 US-listed companies, same days
4%
Median of alleight in ten from 34.7% to 63.8%
50.3%
  • Oct 8, 2026: Short sales 55.6%
  • Oct 9, 2026: Short sales 43.5%
  • Oct 12, 2026: Short sales 46%
  • Oct 13, 2026: Short sales 58.7%
  • Oct 14, 2026: Short sales 57.1%
  • Oct 15, 2026: Short sales 40.9%
  • Oct 16, 2026: Short sales 54.4%
  • Oct 19, 2026: Short sales 38.5%
  • Oct 20, 2026: Short sales 27.8%
  • Oct 21, 2026: Short sales 34.8%
  • Oct 22, 2026: Short sales 49.4%
  • Oct 23, 2026: Short sales 53.7%
  • Oct 26, 2026: Short sales 43.2%
  • Oct 27, 2026: Short sales 56.8%
  • Oct 28, 2026: Short sales 29.8%
  • Oct 29, 2026: Short sales 48.8%
  • Oct 30, 2026: Short sales 40.8%
  • Nov 2, 2026: Short sales 39.3%
  • Nov 3, 2026: Short sales 40.2%
  • Nov 4, 2026: Short sales 19.3%
  • Nov 5, 2026: Short sales 23%
  • Nov 6, 2026: Short sales 33%
  • Nov 9, 2026: Short sales 41.1%
  • Nov 10, 2026: Short sales 36.8%
  • Nov 11, 2026: Short sales 32.5%
  • Nov 12, 2026: Short sales 55.7%
  • Nov 13, 2026: Short sales 46.1%
  • Nov 16, 2026: Short sales 37.3%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

181.4K Insiders' shares0.18% Of the company
  • Gwenn HansenChief Scientific Officer
    Directly123.5K
  • Houte Hans vanChief Financial Officer
    Directly42.7K
  • Julia P GregoryDirector
    Directly10.8K
  • Christine RingChief Legal Officer
    Directly4,406

A lower bound: it counts only the 4 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

18 ETFs holding it2.51% The largest weight (ARKG)
  • ARKGARK Genomic Revolution ETF
    Weight in the fund2.51%
  • XBIState Street(R) SPDR(R) S&P(R) Biotech ETF
    Weight in the fund0.56%
  • LABUDirexion Daily S&P Biotech Bull 3X Shares
    Weight in the fund0.39%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.19%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.11%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.08%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.07%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.05%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.03%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.03%

18 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

211 Managers, Q2 2026$2.8B Value of their positions
  • Q3 2025: Managers 173
  • Q4 2025: Managers 182
  • Q1 2026: Managers 197
  • Q2 2026: Managers 211

Institutional investors by quarter

The fund managers holding NRIX, quarter by quarter, from Q3 2020 to Q2 2025, 20 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 211 managers held 117M shares, worth $2.8B. During the quarter 47 opened a position, 33 closed one, 65 added and 61 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter-1.7%
  • Vestal Point Capital
    In the quarter+24%
  • Deep Track Capital
    In the quarter+22%
  • Rubric Capital Management
    In the quarter+192%
  • FMR
    In the quarter-1.0%
  • Price T Rowe Associates
    In the quarter+65%
  • Morgan Stanley
    In the quarter-3.4%
  • State Street
    In the quarter-9.0%
  • Baker Bros. Advisors
    In the quarter
  • Vanguard Capital Management
    In the quarter+1.5%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Nurix Therapeutics's filings show?

Who buys and sells is one part of Nurix Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about NRIX's shareholders

Didn't find what you were looking for?

Ask us
Have NRIX's insiders bought or sold?

From Jun 2, 2026 to Nov 4, 2026 Nurix Therapeutics's insiders bought 0 and sold $3.7M of shares on the market. 75% of the sales were under set 10b5-1 plans.

Which well-known managers hold NRIX?

5 of the managers we track held the shares on Jun 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $36M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.